HRS Aluglaze (544656)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 20.16% indicates efficient capital usage
• Latest quarter net margin is strong at roughly 19% (₹5 Cr profit on ₹26 Cr sales)
• Company is profitable with positive latest-quarter net profit
• Market cap of ₹470 Cr suggests a small but investable size for retail scrutiny

Concerns

• P/E of 91.36 is extremely expensive with zero sales and profit growth
• Piotroski F-Score of 3/9 points to weak financial health
• No dividend yield, so total return depends entirely on uncertain capital gains
• Critical data missing: book value, debt-to-equity, promoter holding, making valuation and governance assessment impossible

AI Analysis

At ₹244, HRS Aluglaze is asking me to pay ₹470 Cr for a business earning roughly ₹5 Cr on a trailing basis. That is a P/E of 91.36, and what am I getting for that rich price? Zero sales growth and zero profit growth. Graham would call this speculation, not investment. The latest quarter does show some life: ₹26 Cr in sales and ₹5 Cr in net profit, a healthy 19% margin, and the 20.16% ROCE tells me the underlying business can deploy capital reasonably well. But one good quarter does not make a moat. With a Piotroski F-Score of 3 out of 9, the financial health signals are weak, and the absence of book value, debt/equity and promoter holding data leaves too many blind spots. As Buffett says, risk comes from not knowing what you are doing. Here, the market is pricing in perfection, yet the numbers show stagnation. The zero dividend yield means the investor needs capital appreciation alone, and at 91 times earnings with no growth, that hope rests entirely on a re-rating or a sudden acceleration in earnings. I need margin of safety. This stock has none visible. I would patiently wait on the sidelines, watch for consistent quarterly earnings, and demand a far lower price before ever considering this. Value is what you get, and right now the numbers do not support the price.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer